Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$65.4K Hold
260
0.01% 128
2026
Q1
$56.5K Hold
260
0.01% 134
2025
Q4
$59.4K Sell
260
-5
-2% -$1.14K 0.01% 127
2025
Q3
$61.4K Buy
265
+5
+2% +$1.02K 0.01% 127
2025
Q2
$48.3K Sell
260
-42
-14% -$7.81K 0.01% 139
2025
Q1
$63.3K Sell
302
-40
-12% -$7.78K 0.01% 123
2024
Q4
$60.8K Hold
342
0.01% 128
2024
Q3
$67.5K Sell
342
-96
-22% -$17.9K 0.02% 49
2024
Q2
$75.1K Buy
438
+118
+37% +$19.5K 0.02% 46
2024
Q1
$58.3K Buy
+320
New +$55.1K 0.02% 48

Other funds holding ABBV

ESL Trust Services's ABBV Position: Q2 2026 in Review

ESL Trust Services held its AbbVie (ABBV) position steady in Q2 2026 at 260 shares worth $65.4K. The position accounts for 0.01% of the portfolio, ranked #128.

ESL Trust Services first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. The position peaked at $75.1K in Q2 2024. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • ESL Trust Services held 260 shares of AbbVie worth $65.4K as of Q2 2026.
  • ESL Trust Services left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.01% of ESL Trust Services's portfolio in Q2 2026, its #128 holding.
  • ESL Trust Services first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • ESL Trust Services's AbbVie position peaked at $75.1K in Q2 2024.
  • 4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on ESL Trust Services's 13F filing for Q2 2026, filed 13 Aug 2026.